查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540849

2024-2032 年按产品类型、製造技术、分析方法、应用、最终用户和地区分類的生物晶片市场报告

Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球生物晶片市场规模达196亿美元。在下一代定序和晶片实验室技术创新以增强生物晶片能力、政府和私营部门为遗传和分子研究提供大量资金以及对个人化医疗日益增长的需求的推动下，该市场正在经历稳定增长。

生物晶片市场分析：

主要市场驱动力：生物晶片技术的技术进步和后续创新极大地推动了市场。此外，灵敏度、精度和小型化的提高也推动了对这些晶片的需求。市场的其他重要驱动因素包括对个人化医疗的需求不断增长以及对基因组学和蛋白​​质组学研究的投资增加。

主要市场趋势：生物晶片技术与人工智慧和机器学习演算法的整合就是这样的主要趋势之一。它正在促进精准医学、药物发现和诊断的发展，并提高准确性。这可以透过将个人化和预防性治疗模式转向采用生物晶片进行高度详细的分子分析和有针对性的治疗介入来支持。

地理趋势：根据生物晶片市场研究报告，由于医疗保健和生物技术研究的大量投资，北美生物晶片市场份额不断增加。受中国和印度等国家医疗保健支出增加以及对精准医疗日益关注的推动，亚太地区正在快速成长。

竞争格局：市场竞争非常激烈，主要参与者正在投资研发，为市场提供平台创新。同时，主要参与者正在进行策略合作、合併和收购，以在技术专长和地理影响力方面占据优势。生物晶片产业的一些主要市场参与者包括 Agilent Technologies, Inc.、bioMerieux SA、Bio-RAD Laboratories, Inc.、CapitalBio Corporation、Dynamic Biosensors GmbH、EMD Millipore Corporation、Fluidigm Corporation、Illumina, Inc.、Perkinelmer, Inc. .、Thermo Fisher Scientific Inc. 等。

挑战与机会：与生物晶片技术相关的高成本以及监管框架（特别是在某些国家）很复杂，因此该市场的成长面临重大挑战。机会在于生物晶片在农业、法医学、环境监测等快速发展领域的应用延伸，以及生物晶片技术的不断发展。

生物晶片市场趋势：

技术进步与创新

技术的快速进步和生物晶片技术的定期修改推动了市场。生物晶片正在发生变革，例如下一代定序 (NGS)、晶片实验室和微阵列技术可提高生物晶片的功率和有效性。此外，与人工智慧 (AI) 和机器学习 (ML) 演算法整合的基于生物晶片的解决方案的出现正在扩大精准医疗、药物发现和诊断相关的应用。随着生物晶片向基因组学、蛋白质组学和其他分子生物学领域提高灵敏度、准确性和小型化方向发展，生物晶片正在成为必不可少的工具，这提高了生物晶片的市场价值。此外，知名产业参与者在研发方面不断采取倡议，推出先进的生物晶片产品和解决方案，以有效应对医疗保健和生物技术垂直领域的新兴需求，进一步推动市场扩张。

个人化医疗需求不断成长

对个人化医疗的需求不断增长也大大推动了市场的发展。个人化医疗是一种根据遗传、环境和生活方式因素对患者进行个别分析来製定治疗计划的实践，正在加速对生物晶片相关技术的需求。此外，随着医疗保健产业迅速转向个人化和预防性医疗，对生物晶片等先进诊断工具的需求也不断增长。癌症和心血管疾病等慢性疾病发生率的增加也支持了这一趋势，这些疾病需要详细的分子洞察才能进行有效的管理。因此，由于个人化医疗范围不断扩大，生物晶片在临床和研究环境中继续获得更大的接受度，这进一步创造了积极的生物晶片市场前景。

增加基因组学和蛋白​​质组学研究的投资

全球生物晶片市场的关键驱动力之一是增加对基因组和蛋白质组研究的投资。所有政府、学术机构和私营部门都在投资基因组和蛋白质组研究，以了解复杂的生物系统并设计创新的健康解决方案。生物晶片具有广泛的应用，因为它们允许对各种相互作用（例如遗传或蛋白质组学）进行高通量分析和大规模研究。此外，精准农业、法医科学和环境监测等领域的应用日益增长，这些领域都需要高通量分子分析。此外，随着全球不断增长的资金和合作研究不断扩大该市场的范围，对复杂生物晶片平台的需求正在上升，从而引导其促进正在进行的新生命科学研究。

生物晶片市场细分：

IMARC Group提供了全球生物晶片市场报告各细分市场主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品类型、製造技术、分析方法、应用和最终用户对市场进行了分类。

按产品类型划分：

DNA晶片

蛋白质晶片

晶片实验室

酵素晶片

DNA 晶片代表最大的细分市场

该报告根据产品类型对生物晶片市场进行了详细的细分和分析。这包括 DNA 晶片、蛋白质晶片、晶片实验室和酵素晶片。报告称，DNA 晶片是最大的细分市场。

DNA 晶片，也称为 DNA 微阵列，是目前市场上最大的产品类型。广泛的应用范围和技术进步可以支持这一点。这些晶片有助于对遗传资讯进行大规模分析；此类晶片成为基因组学、诊断和个人化医疗的核心工具。可以同时分析数千个基因，从而使癌症基因组学、遗传性疾病筛检和药物基因组学相关的研究发生了里程碑式的变化。它透过升级技术生产出更灵敏、更特异、更有效率的 DNA 晶片，从而提高了采用率。根据生物晶片市场报告，个人基因体学对精准医疗和健康疗法的兴趣日益浓厚，也加速了对 DNA 晶片的需求。市场上的主要参与者正在进行广泛的研究和开发，以推出 DNA 晶片新产品，从而帮助满足医疗保健和生物技术公司不断变化的需求。除此之外，遗传性疾病和慢性疾病发生率的增加需要详细的基因分析，因此 DNA 晶片在当代诊断和治疗中发挥重要作用。因此，DNA 晶片在生物晶片市场中占有更大的份额，因为它们是促进分子生物学和个人医疗保健解决方案的重要组成部分。

依製造技术分解：

微阵列

微流控

微阵列代表最大的细分市场

报告还根据製造技术对生物晶片市场进行了详细的细分和分析。这包括微阵列和微流体。报告称，微阵列占据了最大的市场份额。

微阵列技术因其针对不同应用的多功能性和效率而成为该市场中使用最广泛的製造技术。此方法允许同时分析大量生物资料，并用于基因组学、转录组学和蛋白​​质组学研究。生物晶片市场预测表明，在一次实验中对整个谱系的基因或蛋白质表现进行量化对于药物发现、疾病诊断和个人化医疗将改变游戏规则。新的微阵列技术支援更准确、更快速和规模化的生物晶片製造，从而能够对大部分相应用户群体进行可靠检测。微阵列技术广泛应用于医疗保健和生物资讯学领域，以改善研究活动，并帮助引入新的标靶疗法。此外，它们与现代资料分析技术和生物资讯学平台的整合进一步扩大了微阵列在理解复杂生物过程方面的用途。随着个人化医疗的发展，未来几年对微阵列等准确、高通量分析平台的需求将大幅增加。因此，微阵列技术仍然是市场上领先的製造方法，并在推动生物医学研究向前发展以及改善临床诊断方面发挥基础性作用。

依分析方法细分：

电泳

发光

质谱分析

电讯号

磁性

电泳代表最大的细分市场

报告还根据分析方法对生物晶片市场进行了详细的细分和分析。这包括电泳、发光、质谱、电讯号和磁性。报告称，电泳占据最大的市场份额。

电泳因其在分离技术和生物分子分析中的广泛适用性、强度和精度而成为生物晶片中最主要的分析方法。这也代表了功能基因组学、蛋白质组学和分子生物学中的一项重要技术，透过根据大小和电荷有效分离 DNA、RNA 和蛋白质，从而了解它们的结构和功能。根据生物晶片市场概况，电泳正在多个研究和常规实验室中使用，特别是在与基因图谱、疾病诊断和法医分析相关的任务中。除了是一个强大而准确的系统之外，它还可以与先进的生物晶片技术协同工作，以确保分子分析具有更好的分辨率和更高的通量。电泳技术（包括毛细管电泳和微流体电泳）最近进行了创新，以进一步增强其操作、速度更快并提供更详细的检查。个人化医疗和生物技术领域对高精度分析工具的需求不断增长，电泳将继续占据主导地位。此外，随着复杂的生物系统和疾病机制的不断升级，它巩固了作为市场领先分析方法的核心地位。

按应用划分：

分子分析

杂交

蛋白质

免疫学

生物分子

生物标誌物

其他的

诊断

基因诊断

肿瘤学

发炎

其他的

非生物用途

诊断代表最大的细分市场

报告还根据应用对生物晶片市场进行了详细的细分和分析。这包括分子分析（杂交、蛋白质、免疫学、生物分子、生物标记等）、诊断（基因诊断、肿瘤学、发炎等）和非生物学用途。报告显示，诊断占最大的市场份额。

诊断是市场上最大的应用，因为医疗保健中需要准确、快速且全面的诊断工具。生物晶片正在彻底改变诊断概念，因为它们可以在单一晶片中分析多种生物标记物，有助于早期、准确地检测疾病。因此，这正在不断增加生物晶片的需求。这对于治疗癌症、心血管疾病和新出现的病毒感染等慢性疾病和传染病非常重要。这些因素导致生物晶片整合到诊断平台中，进一步提高了测试的特异性和敏感性，从而根据测试结果，透过及时和有针对性的干预措施，带来更好的患者结果。除此之外，以微阵列和晶片实验室系统形式出现的生物晶片技术的进步使得诊断层面的事情变得更简单、更具成本效益且更容易获得。个人化医疗的兴起进一步提高了基于生物晶片的诊断的风险，因为这些将能够对基因图谱进行分析，以根据个体进行治疗。随着全球医疗保健格局向精准和预防医学的方向不断变化，用于诊断目的的生物晶片的采用正在获得相当大的普及，这实质上将其作为现代医疗诊断的基石，并推动了生物晶片市场的增长。

按最终用户划分：

製药和生物技术公司

医院和诊断中心

学术及研究机构

其他的

製药和生物技术公司代表最大的市场领域

报告还提供了基于最终用户的生物晶片市场的详细细分和分析。这包括製药和生物技术公司、医院和诊断中心、学术和研究机构等。报告显示，製药和生物技术公司占据了最大的市场。

生物晶片产业最大的最终用户是製药和生物技术公司。这可以归因于他们广泛的研究和开发活动以及药物发现和开发过程中对新解决方案的需求增加。生物晶片在高通量筛选、基因分析和生物标记识别等领域为这些领域提供了巨大帮助，以了解疾病机制和随后开发标靶治疗。此外，生物晶片技术使新的技术精确、更快、更便宜的方法成为可能，加速药物开发，并为临床试验的规划提供资讯和便利，从而透过详细的分子洞察将个人化医疗付诸实践。对此，研究企业对生物晶片技术的大量投资是为了提高效率并降低开发成本。此外，生物晶片製造商与製药和生物技术公司之间的密切合作促进了针对特殊研究需求的进一步改进的生物晶片形式。随着对新疗法和个人化治疗方案的需求不断增长带来的持续压力，这些行业对生物晶片的依赖越来越大，它可以在创新和建立竞争优势以应对不断变化的医疗保健环境方面产生关键差异。

按地区划分：

北美洲

美国

加拿大

欧洲

德国

法国

英国

西班牙

俄罗斯

义大利

其他的

亚太地区

中国

日本

印度

韩国

澳洲

其他的

拉丁美洲

墨西哥

巴西

阿根廷

其他的

中东和非洲

土耳其

沙乌地阿拉伯

阿拉伯聯合大公国

其他的

北美市场领先，占据最大的生物晶片市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、西班牙、俄罗斯、义大利等）；亚太地区（中国、印度、日本、韩国、澳洲等）；拉丁美洲（墨西哥、巴西、阿根廷等）；以及中东和非洲（土耳其、沙乌地阿拉伯、阿拉伯联合大公国等）。报告称，北美是生物晶片最大的区域市场。

由于高品质的医疗基础设施和对生物技术研究的大量投资，北美地区是生物晶片市场的最大贡献者，其次是受到技术创新强劲推动的亚太地区。此外，该地区的主权也受到生物技术领域一些主要市场参与者的推动，例如三星生物製品公司和Celltrion，以及政府对研发活动的全面支持。同时，不断增长的慢性疾病和个人化医疗需求进一步推动了生物晶片技术的使用增加。由于基因组学和蛋白​​质组学研究拨款增加了生物晶片市场收入，美国和加拿大等主要国家的该市场的潜在成长机会正在推动区域扩张。此外，北美成熟的製药和生物技术产业的存在使得生物晶片应用能够在不同的医疗保健环境中快速商业化和采用。

本报告回答的关键问题：

  • 迄今为止，全球生物晶片市场表现如何，未来几年将如何表现？
  • 全球生物晶片市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生物晶片市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的生物晶片市场？
  • 依产品类型分類的市场是怎么样的？
  • 生物晶片市场上最具吸引力的产品类型是什么？
  • 基于製造技术的市场区隔是什么？
  • 生物晶片市场上最具吸引力的製造技术是什么？
  • 根据分析方法，市场的细分是什么？
  • 生物晶片市场上最具吸引力的分析方法是什么？
  • 基于应用的市场区隔是什么？
  • 生物晶片市场最有吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 生物晶片市场上最有吸引力的最终用户是谁？
  • 市场竞争结构如何？
  • 谁是全球生物晶片市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物晶片市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • DNA晶片
    • 市场趋势
    • 市场预测
  • 蛋白质晶片
    • 市场趋势
    • 市场预测
  • 晶片实验室
    • 市场趋势
    • 市场预测
  • 酵素晶片
    • 市场趋势
    • 市场预测

第 7 章：市场细分：依製造技术

  • 微阵列
    • 市场趋势
    • 市场预测
  • 微流控
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按分析方法

  • 电泳
    • 市场趋势
    • 市场预测
  • 发光
    • 市场趋势
    • 市场预测
  • 质谱分析
    • 市场趋势
    • 市场预测
  • 电讯号
    • 市场趋势
    • 市场预测
  • 磁性
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按应用

  • 分子分析
    • 杂交
      • 市场趋势
      • 市场预测
    • 蛋白质
      • 市场趋势
      • 市场预测
    • 免疫学
      • 市场趋势
      • 市场预测
    • 生物分子
      • 市场趋势
      • 市场预测
    • 生物标誌物
      • 市场趋势
      • 市场预测
    • 其他的
      • 市场趋势
      • 市场预测
  • 诊断
    • 基因诊断
      • 市场趋势
      • 市场预测
    • 肿瘤学
      • 市场趋势
      • 市场预测
    • 发炎
      • 市场趋势
      • 市场预测
    • 其他的
      • 市场趋势
      • 市场预测
  • 非生物用途
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 医院和诊断中心
    • 市场趋势
    • 市场预测
  • 学术及研究机构
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 俄罗斯
    • 义大利
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: SR112024A2741

The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The market is experiencing steady growth driven by innovations in next-generation sequencing and lab-on-a-chip technologies to enhance biochip capabilities, substantial funding from governments and private sectors for genetic and molecular research, and the increasing demand for personalized medicine.

Biochips Market Analysis:

Major Market Drivers: Advances in technology and subsequent innovations in the technology of biochips greatly fuel the market. Additionally, the rise in sensitivity, accuracy, and miniaturization is also driving the demand for these chips. Other prominent drivers for the market include rising demand for personalized medicine and augmented investment in genomics and proteomics research.

Key Market Trends: The integration of biochip technology with AI and ML algorithms is one such key trend. It is facilitating the development of precision medicine, drug discovery, and diagnostics with enhanced accuracy. This can be supported by shifting personalized and preventive treatment patterns towards the adoption of biochips for highly detailed molecular analyses and targeted therapeutic interventions.

Geographical Trends: According to the biochips market research report, North America represents an increasing biochips market share driven by heavy investment in health care and biotechnology research. Asia-Pacific is rapidly growing, impelled by increasing expenditure on healthcare and a rising focus on precision medicine in countries such as China and India.

Competitive Landscape: The market is quite a competitive space where key players are investing in research and development to offer platform innovations into the market. Concurrently, the major players are entering strategic collaborations, mergers, and acquisitions to get an upper hand on technological expertise and geographical presence. Some of the major market players in the biochips industry include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: The high cost associated with biochip technology, and the regulatory framework, particularly in certain countries, is complex, hence the major challenges to the growth of this market. Opportunities are related to the extension of applications of biochips in fields with fast development, such as agriculture, forensic sciences, and environmental monitoring, coupled with the continuous development of biochip technology.

Biochips Market Trends:

Technological advancements and innovations

The market is propelled by the rapid progress in technology and periodic modifications of biochip technologies. Biochips are transforming, such as the next-generation sequencing (NGS), lab-on-a-chip, and microarray technologies that improve the power and effective performance of biochips. Further, the advent of biochip-based solutions that are integrated with artificial intelligence (AI) and machine learning (ML) algorithms is amplifying precision medicine, drug discovery, and diagnostic-related applications. Biochips are becoming essential tools as they change to greater sensitivity, accuracy, and miniaturization in genomics, proteomics, and other molecular biology fields, which is enhancing biochips market value. Additionally, ongoing initiatives being taken by the prominent industry players in terms of R&D to launch advanced biochip products and solutions that could respond effectively to emerging requirements from healthcare and biotechnology verticals further fuel market expansion.

Growing demand for personalized medicine

The increasing demand for personalized medicine also significantly fuels the market. Personalized medicine as a practice based on individual profiling of patients by genetic, environmental, and lifestyle factors in tailoring treatment plans is accelerating the need for technologies related to biochips. In addition, the requirement for advanced diagnostic tools such as biochips is growing with the healthcare sector rapidly shifting towards personalized and preventive medicine. This trend can be supported by an increase in the incidence of chronic diseases such as cancer and cardiovascular disorders, which need detailed molecular insight for effective management. Thus, due to the growing scope of personalized medicine, biochips continue to get greater acceptance in clinical and research settings which is further creating a positive biochips market outlook.

Increasing investment in genomics and proteomics research

One of the key drivers for the global market of biochips is increasing investments in genome and proteome research. All governments, academic institutions, and private sectors are investing in genomic as well as proteomic studies, to understand complex biological systems and devise innovative health solutions. Biochips find large applications since they permit high-throughput analysis and large-scale studies of various interactions, such as genetically or proteomically. In addition, the growing applications in precision agriculture, forensic sciences, and environmental monitoring, among others, where high-throughput molecular analyses are required. Moreover, the demand for sophisticated biochip platforms is rising as globally growing funding and collaborative research continue to broaden the scope of this market, thus directing it to foster ongoing new life sciences research.

Biochips Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biochips market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, fabrication technique, analysis method, application, and end user.

Breakup by Product Type:

DNA Chip

Protein Chip

Lab-On-a-Chip

Enzyme Chip

DNA Chip represents the largest market segment

The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.

DNA chips, otherwise called DNA microarrays, are currently the largest product type in the market. This can be supported by the wide application spectrum and technological advances. These chips facilitate large-scale analyses of genetic information; such chips become core tools in genomics, diagnostics, and personalized medicine. Thousands of genes can be analyzed simultaneously, hence making landmark changes in research related to cancer genomics, genetic disorder screening, and pharmacogenomics. It is resulting in more sensitive, specific, and efficient DNA chips with upgraded technologies, thereby increasing adoption. According to the biochips market report, the growing interest in precision medicine and health treatments by individual genomics also accelerates the demand for DNA chips. Key players in the marketplace are engaged in extensive research and development to come up with new products in DNA chips, thereby helping the changing requirements of healthcare and biotech companies. Apart from this, increasing incidences of genetic disorders and chronic diseases require detailed genetic profiling, and thus, DNA chips assume a significant role in contemporary diagnostics and therapy. DNA chips, therefore, hold a greater share in the biochips market since they represent a vital constituent in promoting molecular biology and individualistic healthcare solutions.

Breakup by Fabrication Technique:

Microarray

Microfluidic

Microarray represents the largest market segment

A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.

Microarray technology is the most widely used fabrication technique in this market due to its versatility and efficiency for different applications. This method permits large amounts of biological data to be analyzed at the same time and is used in genomics, transcriptomics, and proteomic studies. The biochips market forecast suggests that quantification of gene or protein expression across the spectrum in a single experiment is game-changing for drug discovery, disease diagnosis, and personalized medicine. New microarray technologies support more accurate, faster, and scaled-up biochip fabrication to enable reliable detection over large fractions of the corresponding user population. Microarray technology is widely used in the healthcare and bioinformatics sectors to improve research activities, as well as help introduce new targeted therapies. Additionally, their integration with modern data analysis techniques and bioinformatics platforms is further expanding the use of microarrays for understanding complex biological processes. With the growth of personalized medicine, the coming years will see a great increase in demand for accurate and high-throughput analytical platforms such as microarrays. Hence, microarray technology continues to be the leading method of manufacturing in the marketplace and plays a foundational role in propelling biomedical research forward as well as improving clinical diagnostics.

Breakup by Analysis Method:

Electrophoresis

Luminescence

Mass Spectrometry

Electrical Signals

Magnetism

Electrophoresis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.

Electrophoresis is the most dominant method of analysis in biochips due to its wide applicability, strength, and precision in separation techniques, and the analysis of biological molecules. This also represents a vital technique in functional genomics, proteomics, and molecular biology through the effective separation of DNA, RNA, and proteins, based on size and charge, offering a view into their structure and function. According to the biochips market overview, electrophoresis is being utilized in several research and routine laboratories, especially in tasks related to genetic mapping, disease diagnosis, and forensic analysis. This, in addition to being a robust and accurate system, permitted working in unison with advanced biochip technologies to ensure better resolution and higher throughput of molecular analyses. Electrophoresis techniques, including capillary and microfluidic electrophoresis, have recently been innovated to further enhance its operations, moving faster and offering more detailed examinations. Evident through the increasing need for high-precision analytical tools within the fields of personalized medicine and biotechnology, electrophoresis is set to remain prominent. Moreover, it consolidates a central position as the leading analysis method in the market with the escalating complex biological systems and disease mechanisms.

Breakup by Application:

Molecular Analysis

Hybridization

Protein

Immunological

Biomolecules

Biomarker

Others

Diagnosis

Gene Diagnosis

Oncology

Inflammatory

Others

Non-Biological Usage

Diagnosis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis accounted for the largest market share.

Diagnosis is the largest application in the market as an accurate, fast, and comprehensive diagnostic tool is necessary in healthcare. Biochips are revolutionizing the concept of diagnosis in that they can analyze multiple biomarkers in a single chip, helping in the early and accurate detection of diseases. Therefore, this is escalating the biochips demand. This is important in managing chronic and infectious diseases, such as cancer, cardiovascular disorders, and emerging viral infections. These factors are leading to the integration of biochips in diagnostic platforms, which further resulted in enhanced specificity and sensitivity of tests, thereby leading toward better patient outcomes, based on test results, through timely and targeted interventions. Apart from this, progress in biochip technology in the form of microarrays and lab-on-a-chip systems has made things easier, cost-effective, and more accessible at the diagnostic level. The stakes for diagnostics based on biochips are further raised by the rise of personalized medicine, as these will be able to render analyses of genetic profiles to administer treatments on an individual basis. With the changing landscape of healthcare across the globe toward precision and preventive medicine, the adoption of biochips for diagnostic purposes is gaining considerable ground, which essentially sets this as a cornerstone in modern medical diagnostics and fuels the biochips market growth.

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostics Centers

Academic and Research Institutes

Others

Pharmaceutical and biotechnology companies represent the largest market segment

A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

The largest end users in the biochips industry are pharmaceuticals and biotechnology firms. This can be attributed to their extensive research and development activities and increased demand for new and fresh solutions in drug discovery and development processes. Biochips help these sectors immensely in areas such as high-throughput screening, gene analysis, and biomarker identification for the comprehension of the mechanisms of diseases and the subsequent development of targeted therapies. Additionally, biochip technology makes possible new technologically precise, faster, and less expensive methods that hasten drug development and inform and facilitate the planning of clinical trials, hence putting personalized medicine into action with detailed molecular insight. In regard to this, the heavy investments in biochip technology by the studied firms is to improve efficiency and lower development costs. Moreover, close collaboration between the manufacturers of biochips and pharmaceutical and biotech companies fosters further improved forms of biochips tailored to special research needs. With continued pressure from the rising need for new therapeutics and personalized treatment options, there is a growing reliance on biochips within these industries, and it can create a critical difference in innovating and building a competitive edge to deal with the transforming environment of healthcare.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Spain

Russia

Italy

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Others

Latin America

Mexico

Brazil

Argentina

Others

Middle East and Africa

Turkey

Saudi Arabia

United Arab Emirates

Others

North America leads the market, accounting for the largest biochips market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America represents the largest regional market for biochips.

The North America region is the largest contributor to the biochips market due to high-quality healthcare infrastructure and substantial investments in biotechnology research, followed by Asia-Pacific being robustly driven by technological innovation. Besides, the sovereignty of this region is also driven by some major market players in biotech, such as Samsung Biologics and Celltrion, along with comprehensive government support for R&D activities. Along with this, rising chronic diseases and personalized medicine requirements are further fueling a rise in the usage of biochip technologies. Prospective growth opportunities for this market in major countries such as the U.S. and Canada are propelling regional expansion due to genomics and proteomics research grants which are augmenting the biochips market revenue. In addition, the presence of mature pharmaceutical and biotechnology industries in North America allows expeditious commercialization and adoption of biochip applications across diverse healthcare settings.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biochips industry include:

Agilent Technologies, Inc.

bioMerieux SA

Bio-RAD Laboratories, Inc.

CapitalBio Corporation

Dynamic Biosensors GmbH

EMD Millipore Corporation

Fluidigm Corporation

Illumina, Inc.

Perkinelmer, Inc.

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The leading biochips companies are engaged in research and development with respect to new products and technological innovations to enhance the existing technology. Major companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies execute next-generation sequencing and lab-on-chip systems. This develops sensitivity, accuracy, and throughput, hence meeting demand for precise diagnostic and research tools. Such strategic collaborations, mergers, and acquisitions often allow these firms to develop their product line and increase their geographical presence. They are also integrating the biochip technology with artificial intelligence and machine learning, which enhances the data analysis capability. These major players, therefore, meet changing requirements in personalized medicine, diagnostics, and drug discovery, hence maintaining a competitive edge and accelerating the market growth.

Biochips Market News:

September 4, 2023: Agilent and ACTRIS announced their collaboration to expedite cellular and genetic treatment in Singapore. The new partnership intends to install and operate Agilent's xCELLigence real-time cell analyzer, Seahorse XF technology, and other cell analysis portfolio in the country's largest national cell and gene therapy process development and manufacturing facility at ACTRIS.

August 17, 2023: Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the opening of a new office as well as a state-of-the-art Illumina Solutions Center (ISC) to support the growing customer base in Bengaluru.

Key Questions Answered in This Report:

  • How has the global biochips market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biochips market?
  • What is the impact of each driver, restraint, and opportunity on the global biochips market?
  • What are the key regional markets?
  • Which countries represent the most attractive biochips market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the biochips market?
  • What is the breakup of the market based on the fabrication technique?
  • Which is the most attractive fabrication technique in the biochips market?
  • What is the breakup of the market based on the analysis method?
  • Which is the most attractive analysis method in the biochips market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biochips market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biochips market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biochips market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2023
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2023
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Biochips (DNA Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biochips (DNA Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biochips (Protein Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biochips (Protein Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biochips (Lab-On-a-Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biochips (Lab-On-a-Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biochips (Enzyme Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biochips (Enzyme Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biochips (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biochips (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biochips (Microfluidic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biochips (Microfluidic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biochips (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biochips (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biochips (Luminescence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biochips (Luminescence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biochips (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biochips (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biochips (Electrical Signals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biochips (Electrical Signals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biochips (Magnetism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biochips (Magnetism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biochips (Molecular Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biochips (Molecular Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biochips (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biochips (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biochips (Protein) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biochips (Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biochips (Immunological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biochips (Immunological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biochips (Biomolecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biochips (Biomolecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Biochips (Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Biochips (Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Biochips (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Biochips (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Biochips (Gene Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Biochips (Gene Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Biochips (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Biochips (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Biochips (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Biochips (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Biochips (Non-Biological Usage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Biochips (Non-Biological Usage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Biochips (Hospitals and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Biochips (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Global: Biochips (Academic & Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Global: Biochips (Academic & Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: North America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United States: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Canada: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Spain: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Russia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Italy: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: China: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: India: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Japan: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Australia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 110: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 120: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million US$), 2024-2032
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million US$), 2024-2032
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players